#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nephrotic syndrome Glioblastoma B-cell lymphoma Pancreatic neuroendocrine tumour Lymphatic malformation Deafness Oropharyngeal squamous cell carcinoma Pulmonary tuberculosis Adrenoleukodystrophy Congenital generalised lipodystrophy Systemic candida Leukocyte adhesion deficiency Mantle cell lymphoma stage III Anal fistula Aplastic anaemia More trials…

    Learn about Rare Diseases

    Idiopathic inflammatory myopathy – Trials in Disease Angiosarcoma recurrent – Basic Information Advanced systemic mastocytosis – Life with Disease Pleural mesothelioma malignant – Basic Information Nodal marginal zone B-cell lymphoma – Trials in Disease Retinoblastoma – Trials in Disease MELAS syndrome – Trials in Disease Myxofibrosarcoma – Basic Information Osteosarcoma Langerhans cell sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bupropion Hydrochloride Migalastat Glyceryl Trinitrate Pegfilgrastim Lucerastat Mitomycin NORELGESTROMIN Cusatuzumab Quinidine Sulfate Adenosine RNMB1 Rbd5044 Sodium Lasmiditan Remifentanil Hydrochloride Gimeracil Sotalol Epinephrine Hydrochloride Corticosteroids, Plain Alfacalcidol Tocilizumab More therapies…

    Learn about Your Condition

    Lichenoid keratosis Myofascial pain syndrome Double hit lymphoma Bone marrow failure Psychological trauma Meningioma malignant Aicardi-Goutieres syndrome Post procedural infection Hepatic angiosarcoma Systemic sclerosis pulmonary Lichen sclerosus Lung cancer metastatic Corneal graft rejection Cirrhosis alcoholic Gastrointestinal melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mvantp Zurrjeqw Kflct 2fe Ddgaisaug 4okgf Hfypzyz

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Long-Term Safety and Efficacy of ARO-APOC3 for Adults with Mixed Dyslipidemia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type V hyperlipidaemia
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Hungary The Netherlands Poland

  • Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

    Not recruiting

    3 1
    Investigated Drugs:
    • Dupilumab
    Belgium Bulgaria Greece Hungary Ireland Romania +1

  • Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    • Sjogren’s syndrome
    Investigated Drugs:
    • Ianalumab
    Bulgaria France Germany Greece Hungary Italy +5

  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Bimekizumab
    Belgium Czechia France Germany Hungary Italy +2

  • Study on Obinutuzumab, Chlorambucil, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Chlorambucil
    • Acalabrutinib
    • Obinutuzumab
    Belgium France Germany Hungary Italy Lithuania +3

  • Study on Dostarlimab, Carboplatin, and Paclitaxel for Patients with Recurrent or Advanced Endometrial Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Endometrial cancer stage III
    • Endometrial cancer stage IV
    Investigated Drugs:
    • Dostarlimab
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Finland Germany Greece +7

  • Study on the Effects of Subcutaneous Human Immunoglobulin (Newnorm) for Patients with Primary Immunodeficiency Diseases

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Germany Hungary Italy Poland Slovakia

  • Study of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Warm autoimmune haemolytic anaemia
    Investigated Drugs:
    • Entecavir
    • Epoetin Alfa
    • Ianalumab
    France Germany Hungary Italy Romania Spain

  • Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Golcadomide
    • Pegfilgrastim
    • Apixaban
    Austria Bulgaria Czechia Denmark Finland France +11

  • Study on Bimekizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1
    Investigated Drugs:
    • Bimekizumab
    • Ustekinumab
    Belgium Czechia France Germany Hungary Italy +2
Previous Page
1 … 39 40 41 42 43 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!